Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2021-09-14 15:20:01 UTC |
---|
HMDB ID | HMDB0000265 |
---|
Secondary Accession Numbers | - HMDB0006780
- HMDB00265
- HMDB06780
|
---|
Metabolite Identification |
---|
Common Name | Liothyronine |
---|
Description | Liothyronine is a T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone that is finally delivered and used by the tissues is mainly T3. Liothyronine is mildly toxic by ingestion and is an experimental teratogen. When heated to decomposition it emits toxic fumes of NOx, I(-), and Cl(-) (Sax's Dangerous Properties of Industrial Materials). |
---|
Structure | N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1 |
---|
Synonyms | Value | Source |
---|
3,5,3'-Triiodo-L-thyronine | ChEBI | 3,5,3'-Triiodothyronine | ChEBI | 3,5,3'TRIIODOTHYRONINE | ChEBI | 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine | ChEBI | L-3,5,3'-Triiodothyronine | ChEBI | L-T3 | ChEBI | Liothyroninum | ChEBI | Liotironina | ChEBI | O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine | ChEBI | T3 | ChEBI | Tertroxin | ChEBI | Tresitope | ChEBI | Triiodothyronine | ChEBI | 3,3',5-Triiodo-L-thyronine | Kegg | Thyrolar | Kegg | 3,3',5-Triiodothyronine | HMDB | Cytomel | HMDB | T3 Thyroid hormone | HMDB | Thyroid hormone, T3 | HMDB | Liothyronine sodium | HMDB | 3,3',5'-Triiodo-L-thyronine | HMDB | 3,3',5'-Triiodothyronine | HMDB | 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylalanine | HMDB | Cyronine | HMDB | L-3,3',5-Triiodo-thyronine | HMDB | L-3,3',5-Triiodothyronine | HMDB | L-3-[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]-alanine | HMDB | L-Liothyronine | HMDB | L-Triiodothyronine | HMDB | Liothyronin | HMDB | Triiodo-L-thyronine | HMDB |
|
---|
Chemical Formula | C15H12I3NO4 |
---|
Average Molecular Weight | 650.9735 |
---|
Monoisotopic Molecular Weight | 650.790038137 |
---|
IUPAC Name | (2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid |
---|
Traditional Name | liothyronine |
---|
CAS Registry Number | 6893-02-3 |
---|
SMILES | N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O |
---|
InChI Identifier | InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1 |
---|
InChI Key | AUYYCJSJGJYCDS-LBPRGKRZSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylalanine and derivatives. Phenylalanine and derivatives are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Phenylalanine and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Phenylalanine or derivatives
- Diphenylether
- Diaryl ether
- 3-phenylpropanoic-acid
- Alpha-amino acid
- Amphetamine or derivatives
- L-alpha-amino acid
- Phenoxy compound
- 2-iodophenol
- 2-halophenol
- Phenol ether
- Iodobenzene
- 1-hydroxy-2-unsubstituted benzenoid
- Halobenzene
- Phenol
- Aralkylamine
- Aryl iodide
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- Amino acid
- Ether
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic nitrogen compound
- Primary aliphatic amine
- Organohalogen compound
- Organoiodide
- Organonitrogen compound
- Organooxygen compound
- Primary amine
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Amine
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Liothyronine,1TMS,isomer #1 | C[Si](C)(C)OC1=CC=C(OC2=C(I)C=C(C[C@H](N)C(=O)O)C=C2I)C=C1I | 3500.9 | Semi standard non polar | 33892256 | Liothyronine,1TMS,isomer #2 | C[Si](C)(C)OC(=O)[C@@H](N)CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1 | 3505.5 | Semi standard non polar | 33892256 | Liothyronine,1TMS,isomer #3 | C[Si](C)(C)N[C@@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(=O)O | 3540.4 | Semi standard non polar | 33892256 | Liothyronine,2TMS,isomer #1 | C[Si](C)(C)OC(=O)[C@@H](N)CC1=CC(I)=C(OC2=CC=C(O[Si](C)(C)C)C(I)=C2)C(I)=C1 | 3520.6 | Semi standard non polar | 33892256 | Liothyronine,2TMS,isomer #2 | C[Si](C)(C)N[C@@H](CC1=CC(I)=C(OC2=CC=C(O[Si](C)(C)C)C(I)=C2)C(I)=C1)C(=O)O | 3516.8 | Semi standard non polar | 33892256 | Liothyronine,2TMS,isomer #3 | C[Si](C)(C)N[C@@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(=O)O[Si](C)(C)C | 3485.2 | Semi standard non polar | 33892256 | Liothyronine,2TMS,isomer #4 | C[Si](C)(C)N([C@@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(=O)O)[Si](C)(C)C | 3627.2 | Semi standard non polar | 33892256 | Liothyronine,3TMS,isomer #1 | C[Si](C)(C)N[C@@H](CC1=CC(I)=C(OC2=CC=C(O[Si](C)(C)C)C(I)=C2)C(I)=C1)C(=O)O[Si](C)(C)C | 3509.7 | Semi standard non polar | 33892256 | Liothyronine,3TMS,isomer #1 | C[Si](C)(C)N[C@@H](CC1=CC(I)=C(OC2=CC=C(O[Si](C)(C)C)C(I)=C2)C(I)=C1)C(=O)O[Si](C)(C)C | 3176.4 | Standard non polar | 33892256 | Liothyronine,3TMS,isomer #1 | C[Si](C)(C)N[C@@H](CC1=CC(I)=C(OC2=CC=C(O[Si](C)(C)C)C(I)=C2)C(I)=C1)C(=O)O[Si](C)(C)C | 3131.5 | Standard polar | 33892256 | Liothyronine,3TMS,isomer #2 | C[Si](C)(C)OC1=CC=C(OC2=C(I)C=C(C[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)C=C2I)C=C1I | 3638.7 | Semi standard non polar | 33892256 | Liothyronine,3TMS,isomer #2 | C[Si](C)(C)OC1=CC=C(OC2=C(I)C=C(C[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)C=C2I)C=C1I | 3317.3 | Standard non polar | 33892256 | Liothyronine,3TMS,isomer #2 | C[Si](C)(C)OC1=CC=C(OC2=C(I)C=C(C[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C)C=C2I)C=C1I | 3305.8 | Standard polar | 33892256 | Liothyronine,3TMS,isomer #3 | C[Si](C)(C)OC(=O)[C@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)N([Si](C)(C)C)[Si](C)(C)C | 3610.9 | Semi standard non polar | 33892256 | Liothyronine,3TMS,isomer #3 | C[Si](C)(C)OC(=O)[C@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)N([Si](C)(C)C)[Si](C)(C)C | 3279.4 | Standard non polar | 33892256 | Liothyronine,3TMS,isomer #3 | C[Si](C)(C)OC(=O)[C@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)N([Si](C)(C)C)[Si](C)(C)C | 3301.0 | Standard polar | 33892256 | Liothyronine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1=CC=C(OC2=C(I)C=C(C[C@H](N)C(=O)O)C=C2I)C=C1I | 3786.6 | Semi standard non polar | 33892256 | Liothyronine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H](N)CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1 | 3777.3 | Semi standard non polar | 33892256 | Liothyronine,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(=O)O | 3786.9 | Semi standard non polar | 33892256 | Liothyronine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)[C@@H](N)CC1=CC(I)=C(OC2=CC=C(O[Si](C)(C)C(C)(C)C)C(I)=C2)C(I)=C1 | 4009.3 | Semi standard non polar | 33892256 | Liothyronine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC(I)=C(OC2=CC=C(O[Si](C)(C)C(C)(C)C)C(I)=C2)C(I)=C1)C(=O)O | 4035.1 | Semi standard non polar | 33892256 | Liothyronine,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N[C@@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(=O)O[Si](C)(C)C(C)(C)C | 3997.9 | Semi standard non polar | 33892256 | Liothyronine,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)N([C@@H](CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(=O)O)[Si](C)(C)C(C)(C)C | 4071.1 | Semi standard non polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Liothyronine GC-MS (Non-derivatized) - 70eV, Positive | splash10-05a9-5090378000-014ef55558b58a3d38f2 | 2017-08-28 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Liothyronine GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Liothyronine GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Liothyronine GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Liothyronine GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Liothyronine GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Liothyronine GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Liothyronine GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Liothyronine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Liothyronine GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Liothyronine GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Liothyronine GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Liothyronine GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Liothyronine GC-MS (TBDMS_2_3) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Liothyronine GC-MS (TBDMS_2_4) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Liothyronine GC-MS ("Liothyronine,1TMS,#1" TMS) - 70eV, Positive | Not Available | 2021-11-02 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Liothyronine Quattro_QQQ 10V, N/A-QTOF (Annotated) | splash10-000i-0009001000-1d47041336da63b556e4 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Liothyronine Quattro_QQQ 25V, N/A-QTOF (Annotated) | splash10-000i-1009001000-15f70073b9018f013c9c | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Liothyronine Quattro_QQQ 40V, N/A-QTOF (Annotated) | splash10-000i-0009000000-71c231d7a3ab505815ff | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Liothyronine LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative-QTOF | splash10-0udi-0000009000-f932659d1e6d8a622985 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Liothyronine LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative-QTOF | splash10-0udi-0000009000-6506a7a71dab928abfb0 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Liothyronine LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative-QTOF | splash10-0fc0-0700119000-1df6db0e3031eb2739fa | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Liothyronine LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative-QTOF | splash10-004i-0900000000-973fc871534b19242cc8 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Liothyronine LC-ESI-QQ (API3000, Applied Biosystems) 50V, Negative-QTOF | splash10-004i-0900000000-ac3c4a198bb017dc7ccc | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Liothyronine LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive-QTOF | splash10-0udi-0000009000-2770ece749a9fa1042f4 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Liothyronine LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive-QTOF | splash10-0udi-0000009000-881174c66da97022d645 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Liothyronine LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive-QTOF | splash10-0a4i-0000019000-6f798ae76702a3053339 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Liothyronine LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive-QTOF | splash10-0a4i-0000219000-d2ca9f0cc3c1b47176b5 | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Liothyronine LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive-QTOF | splash10-056r-0021915000-6f3810619f383bce651a | 2012-08-31 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Liothyronine LC-ESI-QQ , negative-QTOF | splash10-0udi-0000009000-f932659d1e6d8a622985 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Liothyronine LC-ESI-QQ , negative-QTOF | splash10-0udi-0000009000-6506a7a71dab928abfb0 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Liothyronine LC-ESI-QQ , negative-QTOF | splash10-0fc0-0700119000-1df6db0e3031eb2739fa | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Liothyronine LC-ESI-QQ , negative-QTOF | splash10-004i-0900000000-973fc871534b19242cc8 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Liothyronine LC-ESI-QQ , negative-QTOF | splash10-004i-0900000000-ac3c4a198bb017dc7ccc | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Liothyronine LC-ESI-QQ , positive-QTOF | splash10-0udi-0000009000-2770ece749a9fa1042f4 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Liothyronine 10V, Positive-QTOF | splash10-0pb9-0000009000-4d60e144164273111464 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Liothyronine 20V, Positive-QTOF | splash10-0a4i-0000149000-87babecf610c68223da5 | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Liothyronine 40V, Positive-QTOF | splash10-016r-0039010000-b57f6dd23e6456cf7c1e | 2017-07-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Liothyronine 10V, Negative-QTOF | splash10-0002-0010009000-50e441d89395debe176b | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Liothyronine 20V, Negative-QTOF | splash10-001j-0050139000-a259e39ad1204b60b373 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Liothyronine 40V, Negative-QTOF | splash10-00e9-9262431000-bcc1f7554c4e309cef17 | 2017-07-26 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 600 MHz, 100%_DMSO, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, 100%_DMSO, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm
- Extracellular
- Membrane (predicted from logP)
|
---|
Biospecimen Locations | |
---|
Tissue Locations | - Adipose Tissue
- Adrenal Gland
- Epidermis
- Fibroblasts
- Intestine
- Neuron
- Placenta
- Platelet
- Skeletal Muscle
- Testis
- Thyroid Gland
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.0029 +/- 0.00019 uM | Children (1-13 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.002 +/- 0.0006 uM | Adolescent (13-18 years old) | Female | Normal | | details | Blood | Detected and Quantified | 0.000013 - 0.000028 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.0000038 - 0.0000060 uM | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.0000031-0.0000077 uM | Adult (>18 years old) | Not Specified | Normal | | details | Saliva | Detected and Quantified | 0.0 - 1.0 uM | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.0011 +/- 0.00024 uM | Children (1-13 years old) | Both | Malnutrition (type kwashiorkor and marasmus) | | details | Blood | Detected and Quantified | 0.0014 +/- 0.0004 uM | Adolescent (13-18 years old) | Female | Anorexia nervosa | | details | Blood | Detected and Quantified | 0.00169 uM | Adult (>18 years old) | Female | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | | details | Blood | Detected and Quantified | 0.0000041 uM | Adult (>18 years old) | Female | Proprotein Convertase 1/3 Deficiency | | details | Urine | Detected and Quantified | 0.00075 +/- 0.00033 umol/mmol creatinine | Adult (>18 years old) | Both | Hyperthyroidism | | details | Urine | Detected and Quantified | 0.000014 +/- 0.000015 umol/mmol creatinine | Adult (>18 years old) | Both | Hypothyroidism | | details |
|
---|
Predicted Concentrations |
---|
| |
Blood | 0.000 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Anorexia nervosa |
---|
- Capo-chichi CD, Gueant JL, Lefebvre E, Bennani N, Lorentz E, Vidailhet C, Vidailhet M: Riboflavin and riboflavin-derived cofactors in adolescent girls with anorexia nervosa. Am J Clin Nutr. 1999 Apr;69(4):672-8. [PubMed:10197568 ]
| Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency |
---|
- Hattori N, Ishihara T, Moridera K, Hino M, Ikekubo K, Kurahachi H: A case of late-onset congenital adrenal hyperplasia due to partial 3 beta-hydroxysteroid dehydrogenase deficiency. Endocr J. 1993 Feb;40(1):107-9. [PubMed:7951484 ]
| Proprotein Convertase 1/3 Deficiency |
---|
- O'Rahilly S, Gray H, Humphreys PJ, Krook A, Polonsky KS, White A, Gibson S, Taylor K, Carr C: Brief report: impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. N Engl J Med. 1995 Nov 23;333(21):1386-90. doi: 10.1056/NEJM199511233332104. [PubMed:7477119 ]
| Hyperthyroidism |
---|
- Yoshida K, Sakurada T, Kaise N, Yamamoto M, Kaise K, Saito S, Yoshinaga K: Measurement of triiodothyronine in urine. Tohoku J Exp Med. 1980 Dec;132(4):389-95. [PubMed:7256725 ]
| Hypothyroidism |
---|
- Yoshida K, Sakurada T, Kaise N, Yamamoto M, Kaise K, Saito S, Yoshinaga K: Measurement of triiodothyronine in urine. Tohoku J Exp Med. 1980 Dec;132(4):389-95. [PubMed:7256725 ]
|
|
---|
Associated OMIM IDs | - 606788 (Anorexia nervosa)
- 201810 (Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency)
- 600955 (Proprotein Convertase 1/3 Deficiency)
|
---|
External Links |
---|
DrugBank ID | DB00279 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | Not Available |
---|
KEGG Compound ID | C02465 |
---|
BioCyc ID | CPD-10813 |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Triiodothyronine |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 5920 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 18258 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | TRIODTHY |
---|
MarkerDB ID | MDB00000128 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Salamonczyk, Grzegorz M.; Oza, Vibha B.; Sih, Charles J. A concise synthesis of thyroxine (T4) and 3,5,3'-triiodo-L-thyronine (T3). Tetrahedron Letters (1997), 38(40), 6965-69 |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Schwartz CE, May MM, Carpenter NJ, Rogers RC, Martin J, Bialer MG, Ward J, Sanabria J, Marsa S, Lewis JA, Echeverri R, Lubs HA, Voeller K, Simensen RJ, Stevenson RE: Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. Am J Hum Genet. 2005 Jul;77(1):41-53. Epub 2005 May 11. [PubMed:15889350 ]
- Gil'miiarova FN, Pervova IuV, Radomskaia VM, Gergel' NI, Tarasova SV: [Levels of unified metabolites and thyroid hormones in blood and oral fluid of children with minimal brain dysfunction]. Biomed Khim. 2004 Mar-Apr;50(2):204-10. [PubMed:15179829 ]
- Escobar-Morreale HF, Botella-Carretero JI, Gomez-Bueno M, Galan JM, Barrios V, Sancho J: Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann Intern Med. 2005 Mar 15;142(6):412-24. [PubMed:15767619 ]
- Stalenheim EG: Long-term validity of biological markers of psychopathy and criminal recidivism: follow-up 6-8 years after forensic psychiatric investigation. Psychiatry Res. 2004 Jan 1;121(3):281-91. [PubMed:14675747 ]
- Zimmermann-Belsing T, Dreyer M, Holst JJ, Feldt-Rasmussen U: The relationship between the serum leptin concentrations of thyrotoxic patients during treatment and their total fat mass is different from that of normal subjects. Clin Endocrinol (Oxf). 1998 Nov;49(5):589-95. [PubMed:10197073 ]
- Holt PJ: In vitro responses of the epidermis to triiodothyronine. J Invest Dermatol. 1978 Sep;71(3):202-4. [PubMed:690484 ]
- Mizuma H, Murakami M, Mori M: Thyroid hormone activation in human vascular smooth muscle cells: expression of type II iodothyronine deiodinase. Circ Res. 2001 Feb 16;88(3):313-8. [PubMed:11179199 ]
- Himms-Hagen J: Brown adipose tissue thermogenesis: interdisciplinary studies. FASEB J. 1990 Aug;4(11):2890-8. [PubMed:2199286 ]
- Gledhill RF, Dessein PH, Van der Merwe CA: Treatment of Raynaud's phenomenon with triiodothyronine corrects co-existent autonomic dysfunction: preliminary findings. Postgrad Med J. 1992 Apr;68(798):263-7. [PubMed:1409189 ]
- Kassem M, Brixen K, Mosekilde L, Blum WF, Flyvbjerg A: Effects of growth hormone treatment on serum levels of insulin-like growth factors (IGFs) and IGF binding proteins 1-4 in postmenopausal women. Clin Endocrinol (Oxf). 1998 Dec;49(6):747-56. [PubMed:10209562 ]
- Llewellyn L, Ramsurn VP, Wigham T, Sweeney GE, Power DM: Cloning, characterisation and expression of the apolipoprotein A-I gene in the sea bream (Sparus aurata). Biochim Biophys Acta. 1998 Nov 8;1442(2-3):399-404. [PubMed:9804999 ]
- Dutkiewicz S, Witeska A, Nauman A: The deiodination of thyroxine to triiodothyronine in the testes of patients with prostate cancer. Int Urol Nephrol. 1995;27(1):81-5. [PubMed:7615374 ]
- Rosenbaum M, Goldsmith R, Bloomfield D, Magnano A, Weimer L, Heymsfield S, Gallagher D, Mayer L, Murphy E, Leibel RL: Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest. 2005 Dec;115(12):3579-86. [PubMed:16322796 ]
- Urcelay E, Jareno MA, Menaya J, Parrilla R, Ayuso MS, Martin-Requero A: Cloning and functional characterization of the 5' regulatory region of the human mitochondrial glycerol-3-phosphate dehydrogenase gene. Lack of 3,5,3'-triiodothyronine responsiveness in adipose tissue. Eur J Biochem. 2000 Dec;267(24):7209-17. [PubMed:11106433 ]
- Lebon V, Dufour S, Petersen KF, Ren J, Jucker BM, Slezak LA, Cline GW, Rothman DL, Shulman GI: Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle. J Clin Invest. 2001 Sep;108(5):733-7. [PubMed:11544279 ]
- Iwao H, Abe Y: [Expression of the renin and angiotensinogen genes]. Nihon Yakurigaku Zasshi. 1991 Jan;97(1):1-11. [PubMed:2045011 ]
- Calvo R, Obregon MJ, Ruiz de Ona C, Escobar del Rey F, Morreale de Escobar G: Congenital hypothyroidism, as studied in rats. Crucial role of maternal thyroxine but not of 3,5,3'-triiodothyronine in the protection of the fetal brain. J Clin Invest. 1990 Sep;86(3):889-99. [PubMed:2394838 ]
- Haas MJ, Fishman M, Mreyoud A, Mooradian AD: Thyroid hormone responsive protein (THRP) mediates thyroid hormone-induced cytotoxicity in primary neuronal cultures. Exp Brain Res. 2005 Jan;160(4):424-32. Epub 2004 Oct 15. [PubMed:15490139 ]
|
---|